Suchergebnisse - "Cost-effectiveness"

PubPharm (180)

1

Cost-effectiveness analysis of a vaccine for Helicobacter pylori in southern Europe

enthalten in: Revista espanola de salud publica | 2024

von Arcos-Machancoses, J. | Romero Prada, M. | Crehuá Gaudiza, E. | +1

2

The role and impact of health economics in the optimization of patient care in osteoarthritis: insights from a practical example

in: Global & Regional Health Technology Assessment | 2024

von Mickaël Hiligsmann | Olivier Bruyère

3

A cost-effectiveness analysis of a novel algorithm to sequentially diagnose leprosy based on manufactured tests under the SUS perspective

in: Cadernos de Saúde Pública | 2024

von Milene Rangel da Costa | Carlos Alberto da Silva Magliano | Bruno Monteiro Barros | +6

4

Cost-effectiveness analysis high flow oxygen therapy in the treatment of SARS-CoV-2 pneumonia

enthalten in: Journal of healthcare quality research | 2023

von González-Castro, A. | Cuenca Fito, E. | Fernandez, A. | +5

5

Cost-effectiveness of treatment of type 2 diabetes mellitus in México

enthalten in: Revista medica del Instituto Mexicano del Seguro Social | 2023

von Pérez-Lozano, D. | Camarillo-Nava, V. | Juárez-Zepeda, T. | +5

6

Cost-effectiveness analysis of abemaciclib with endocrine therapy (ET) versus ET alone for HR+, HER2−, node-positive, high-risk early breast cancer in Italy

in: Global & Regional Health Technology Assessment | 2023

von Alison Davie | Sory Traoré | Massimo Giovannitti | +4

7

Cost-effectiveness study of prophylaxis with emicizumab versus bypassing agents in patients with severe hemophilia A in Peru

enthalten in: Medwave | 2022

von Bitrán, R. | Peña, C. | Arpón, P. | +5

8

Criterios de evaluación de nuevas tecnologías en salud que utilizan en las Instituciones Prestadoras de Servicios de Salud en Antioquia, Colombia: estudio transversal

in: Medicina U.P.B. | 2022

von Juan Guillermo Barrientos Gómez | Laura Becerra Ruiz | María Alejandra Tobón Arango | +2

9

Drugs price and reimbursement regulation: comparators, endpoints and role of the cost-effectiveness

in: Global & Regional Health Technology Assessment | 2022

von Claudio Jommi | Giovanni Apolone | Giovanna Scroccaro | +31

10

Clinical and economic consequences of ozenoxacin vs. other topical antibiotics for the treatment of impetigo: a real-life study in Spain

in: Global & Regional Health Technology Assessment | 2022

von Jaime Rodríguez Quintosa | Cintia Cristina Ago | Antoni Sicras Mainar | +2

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[18]